These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32357817)

  • 1. Research Progress in Flavonoids as Potential Anticancer Drug Including Synergy with Other Approaches.
    Hussain Y; Luqman S; Meena A
    Curr Top Med Chem; 2020; 20(20):1791-1809. PubMed ID: 32357817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatment.
    Vazhappilly CG; Amararathna M; Cyril AC; Linger R; Matar R; Merheb M; Ramadan WS; Radhakrishnan R; Rupasinghe HPV
    J Nutr Biochem; 2021 Aug; 94():108623. PubMed ID: 33705948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review.
    Abdifetah O; Na-Bangchang K
    Int J Nanomedicine; 2019; 14():5659-5677. PubMed ID: 31632004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoid Nanoparticles: A Promising Approach for Cancer Therapy.
    Dobrzynska M; Napierala M; Florek E
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32887473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Phenolic Acids and Flavonoids as Potential Anti-Cancer Agents: Current State of the Art and Future Perspectives.
    Bonta RK
    Anticancer Agents Med Chem; 2020; 20(1):29-48. PubMed ID: 31648651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability challenges associated with development of anti-cancer phenolics.
    Gao S; Hu M
    Mini Rev Med Chem; 2010 Jun; 10(6):550-67. PubMed ID: 20370701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy.
    Aiello P; Consalvi S; Poce G; Raguzzini A; Toti E; Palmery M; Biava M; Bernardi M; Kamal MA; Perry G; Peluso I
    Semin Cancer Biol; 2021 Feb; 69():150-165. PubMed ID: 31454670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects.
    Khan H; Ullah H; Martorell M; Valdes SE; Belwal T; Tejada S; Sureda A; Kamal MA
    Semin Cancer Biol; 2021 Feb; 69():200-211. PubMed ID: 31374244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids as Prospective Aromatase Inhibitors in Breast Cancer Prevention/ Therapy.
    Seth R; Kushwaha S; Luqman S; Meena A
    Curr Mol Pharmacol; 2021; 14(6):1112-1124. PubMed ID: 33568041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into Potential Anticancer Activity of Algal Flavonoids: Current Status and Challenges.
    Ferdous UT; Balia Yusof ZN
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34833937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baicalin mediated regulation of key signaling pathways in cancer.
    Singh S; Meena A; Luqman S
    Pharmacol Res; 2021 Feb; 164():105387. PubMed ID: 33352232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotherapeutics to overcome conventional cancer chemotherapy limitations.
    Chidambaram M; Manavalan R; Kathiresan K
    J Pharm Pharm Sci; 2011; 14(1):67-77. PubMed ID: 21501554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavonoids as anticancer agents: structure-activity relationship study.
    López-Lázaro M
    Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):691-714. PubMed ID: 12678721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies.
    Chen H; Gao Y; Wu J; Chen Y; Chen B; Hu J; Zhou J
    Cancer Lett; 2014 Nov; 354(1):5-11. PubMed ID: 25128647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of diabetes mellitus on pharmacokinetics, pharmacodynamics and adverse drug reactions of anticancer drugs.
    Mashayekhi-Sardoo H; Mohammadpour AH; Nomani H; Sahebkar A
    J Cell Physiol; 2019 Nov; 234(11):19339-19351. PubMed ID: 31017666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary flavonoids in cancer therapy and prevention: substrates and inhibitors of cytochrome P450 CYP1 enzymes.
    Androutsopoulos VP; Papakyriakou A; Vourloumis D; Tsatsakis AM; Spandidos DA
    Pharmacol Ther; 2010 Apr; 126(1):9-20. PubMed ID: 20153368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the delivery of disulfiram: a critical analysis of promising approaches to improve its pharmacokinetic profile and anticancer efficacy.
    Farooq MA; Aquib M; Khan DH; Hussain Z; Ahsan A; Baig MMFA; Wande DP; Ahmad MM; Ahsan HM; Jiajie J; Wang B
    Daru; 2019 Dec; 27(2):853-862. PubMed ID: 31758497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Perspectives of the Applications of Polyphenols and Flavonoids in Cancer Therapy.
    Montané X; Kowalczyk O; Reig-Vano B; Bajek A; Roszkowski K; Tomczyk R; Pawliszak W; Giamberini M; Mocek-Płóciniak A; Tylkowski B
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32717865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of liposomal anticancer agents to determine the roles of drug pharmacodistribution and P-glycoprotein (PGP) blockade in overcoming multidrug resistance (MDR).
    Krishna R; Mayer LD
    Anticancer Res; 1999; 19(4B):2885-91. PubMed ID: 10652569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.